Certified by Founder Lodge
adMare BioInnovations
Canada - ND INVESTOR
1 Disclosed Funding Rounds $142,000,000
2 Participating Investments
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
With offices in Montreal, Vancouver and Toronto, adMare is building Canada’s life science industry from sea to sea. With a strong track record of globally-competitive scientific discovery, Ca
| Company | Date | Round | Raised |
|---|---|---|---|
 Abdera Therapeutics | April, 24 ,2023 | Series B | $142,000,000 |
 Specific Biologics | October, 17 ,2023 | Unknown |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Further AI | $5,000,000 | (Apr 3, 2025)
SchoolAI | $25,000,000 | (Apr 3, 2025)
Vivere | $7,500,000 | (Apr 3, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
TwinKnowledge | $3,700,000 | (Apr 3, 2025)
